A flurry of announcements Monday morning from Valeant Pharmaceuticals sent its stock surging more than 10 percent when the stock market opened.
Valeant said it has launched a search to replace chief executive officer J. Michael Pearson. In addition, William Ackman, CEO of Pershing Square Capital Management, which owns 9 percent of the shares, is joining the board of directors.
